A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/ hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 1, 2011, Pages 21-32

  Waxmonsky, James G ^a,b   Waschbusch, Daniel A ^a,b   Akinnusi, Opeoluwa ^b   Pelham, William E ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; COMPARATIVE STUDY; CONDUCT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MORNING DOSAGE; OPPOSITIONAL DEFIANT DISORDER; PRESCHOOL CHILD; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH PAIN; TREATMENT DURATION; TREATMENT RESPONSE; WECHSLER INTELLIGENCE SCALE;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CHILD; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PARENTS; PROPYLAMINES; SCHOOLS; TREATMENT OUTCOME;

EID: 79951524386     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.0042     Document Type: Article

References (41)

1. Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J, 303 Study Group: Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:1364-1373, 2008.
2. Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Bieder-man J, Secnik K: Validity of pilot Adult ADHD Self-Report Rating Scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry 18:145-148, 2006. (Pubitemid 44576434)
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
5. Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L, The Atomoxetine ADHD/ ODD Study Group: Atomoxetine for the treatment of attention-deficit hyperactivity disorder and oppositional defiant disorder. Pediatrics 121:e314-e320, 2008. (Pubitemid 351198437)
6. Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MW: Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: A meta-analysis of controlled clinical data. Psychopharmacology (Berl) 190:31-41, 2007. (Pubitemid 44885341)
7. Block SL, Kelsey D, Coury D, Lewin D, Quintana H, Sutton VK, Schuh KJ, Allen AJ, Sumner CR: Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: Comparison of morning and evening dosing. Clin Pediatr (Phila) 48:723-733, 2009.
8. Fabiano GA, Pelham WE, Waschbusch DA, Gnagy EM, Lahey BB, Chronis AM, Onyango AN, Kipp H, Lopez-Williams A, Burrows-MacLean L: A practical impairment measure: Psychometric properties of the Impairment Rating Scale in samples of children with attention-deficit/hyperactivity disorder and two school-based samples. J Clin Child Adolesc 35:369-385, 2006. (Pubitemid 44230666)
9. Fabiano GA, Pelham WE, Waschbusch DA, Massetti GM, Yu J, Vujnovic R, Pariseau M, Naylor J, Robins M, Carnefix T, Greiner AR, Volker M, Lopata C: Enhancing the effectiveness of special education programming for children with attention-deficit/hyper-activity disorder using a daily report card. Sch Psychol Rev 39:219- 239, 2010.
10. Greenhill LL, Newcorn JH, Gao H, Feldman PD: Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine. J Am Acad Child Adolesc Psychiatry 46:566-572, 2007. (Pubitemid 46642573)
11. Johnston C, Mash EJ: Families of children with attention-deficit/ hyperactivity disorder: Review and recommendations for future research. Clin Child Fam Psychol 4:183-207, 2001. (Pubitemid 33610771)
12. Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ: Once-daily atomoxetine treatment for children with attention-deficit/ hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics 114:e1-e8, 2004.
13. Kratochvil C, Michelson D, Newcon JH, Weiss MD, Busner J, Moore RJ, Ruff, DR, Ramsey J, Dickson E, Turgay A, Saylor KE, Luber S, Vaughan B, Allen AJ, The Atomoxetine High-Dose Study Group: High dose atomoxetine treatment of ADHD in youths with limited repsonses to standard doses. J Am Acad Child Adolesc Psychiatry 46:1128-1137, 2007. (Pubitemid 47295924)
14. Loney J, Milich R: Hyperactivity, inattention, and aggression in clinical practice. In Advances in Developmental and Behavioral Pediatrics, edited by M. Wolraich, DK. Routh. Greenwich, CT: JAI, 1982, pp. 113-147.
15. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J, Treatment for Adolescents with Depression Study (TADS) Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS). JAMA 292:807-820, 2004. (Pubitemid 39079667)
16. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D: Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. Am J Psychiatry 159:1896-1901, 2002. (Pubitemid 35283256)
17. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, Atomoxetine ADHD Study Group: Atomoxetine in the treatment of children and adolescents with attention-deficit/ hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 108:E83, 2001.
18. Nakao K, Treas J: Updating occupational prestige and socioeconomic status: How the new measures measure up. Sociol Methodol 24: 1-72, 1994.
19. Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D: Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 44:240-248, 2005. (Pubitemid 40299837)
20. Newcorn JH, Sutton VK, Weiss MD, Sumner CR: Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: The integrated data exploratory (IDEA) study. J Am Acad Child Adolesc Psychiatry 48:511-518, 2009.
21. NIMH-DISC Editorial Board: The National Institute of Mental Health Diagnostic Interview Schedule for Children. New York: Columbia University, 1999.
22. Pelham WE: Attention Deficit Hyperactivity Disorder: Diagnosis, Assessment, Nature, Etiology, and Treatment. Amherst, NY: Comprehensive Treatment for ADD, 2002.
23. Pelham WE: Disruptive Behavior Disorders Interview. Buffalo, NY: Comprehensive Treatment of ADHD, 1998.
24. Pelham WE: Pharmacotherapy for children with attention-deficit hy-peractivity disorder. Sch Psychol Rev 22:199-227, 1993.
25. Pelham WE, Burrows-MacLean L, Gnagy EM, Coles EK, Wymbs BT, Chacko A, Walker KS, Arnold F, Garefino A, Robb J, Onyango AN, Fabiano GA, Hoffman MT, Waxmonsky J, Massetti GM: Behavioral and pharmacological treatment for children with ADHD. In Annual Convention of the American Psychological Association. Washington, DC, 2005a.
26. Pelham WE, Burrows-MacLean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT: Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psycho-pharmacol 13:111-126, 2005b. (Pubitemid 40791820)
27. Pelham WE, Gnagy EM, Greenslade KE, Milich R: Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 31:210-218, 1992.
28. Pelham WE, Greiner AR, Gnagy EM: Student Behavior Teacher Response Observation Code Manual, 2008a.
29. Pelham WE, Massetti GM, Waschbusch DA, Yu J: Effects of a school-wide social and character development intervention in children with disruptive behavior problems. In Annual Conference of the Institute for Education Sciences. Washington DC, 2008b.
30. Pelham WE, Milich R, Murphy DA, Murphy HA: Normative data on the IOWA Conners teacher rating scale. J Clin Child Psychol 18:259-262, 1989.
31. Poznanski EO, Mokros HB: Children's Depression Rating Scale- Revised (CDRS-R) Manual. Los Angeles, CA: Western Psychological Services, 1995.
32. Psychological Corporation: Wechsler Individual Achievement Test, 2nd ed. San Antonio: Author, 2002.
33. Spencer T, Heligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ: Results from 2 proof-of-concept placebo-controlled studies of atomoxetine in children with attention-deficit/ hyperactivity disorder. J Clin Psychiatry 63:1140-1147, 2002. (Pubitemid 36084059)
34. Waschbusch DA, Pelham WE, Waxmonsky J, Johnston C: Are there placebo effects in the medication treatment of children with ADHD? J Dev Behav Pediatr 30:158-168, 2009.
35. Waschbusch DA, Willoughby MT: Parent and teacher ratings on the IOWA Conners Rating Scale. J Psychopathol Behav 30:180-192, 2008. (Pubitemid 351950684)
36. Waxmonsky J, Nonstimulant therapies for attention-deficit hyperac-tivity disorder (ADHD) in children and adults. Essent Psycho-pharmacol 6:262-276, 2005.
37. Waxmonsky JG, Waschbusch DA, Pelham WE, Dragnac-Cordona L, Rotella B, Ryan L: Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with and without attention-deficit/ hyperactivity disorder. J Clin Psychiatry 77:1535-1551, 2010.
38. Wechsler D: Wechsler Intelligence Scale for Children, 3rd ed. New York: Psychological Corporation, 1991.
39. Weiss MD, Tannock R, Kratochvil C, Dunn D, Velez-Boras J, Tho-mason C, Tamura R, Kelsey D, Stevens L, Allen AJ: A randomized placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 44:647-655, 2005. (Pubitemid 40875359)
40. Weiss MD, Virani A, Wasdell M, Faulkner L, Rea K, Freeman RD, Weiss G, Jokhani V: Atomoxetine in clinical practice. Future Neurol 1:249-258, 2006.
41. Wymbs BT, Pelham WE, Molina BSG, Gnagy EM, Wilson TK, Greenhouse JB: Rate and predictors of divorce among parents of youths with ADHD. J Consult Clin Psychol 76:735-744, 2008.